Loading...
The University of Chicago Header Logo
Keywords
Last Name
Institution

Search Results (628)

Click the Why column to see why an item matched the search.

MatchTypeWhy
Perspectives in immunotherapy: meeting report from the "Immunotherapy Bridge", Napoli, November 30th 2016.Academic Article Why?
Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of bladder carcinoma.Academic Article Why?
IMMUNOTHERAPY. Could microbial therapy boost cancer immunotherapy?Academic Article Why?
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of lymphoma.Academic Article Why?
Matrix-binding checkpoint immunotherapies enhance antitumor efficacy and reduce adverse events.Academic Article Why?
A novel series of conferences tackling the hurdles confronting the translation of novel cancer immunotherapies.Academic Article Why?
Emerging strategies in regulatory T-cell immunotherapies.Academic Article Why?
Targeted agents and immunotherapies: optimizing outcomes in melanoma.Academic Article Why?
Targeted antibody and cytokine cancer immunotherapies through collagen affinity.Academic Article Why?
Challenges in clinical design of immunotherapy trials for malignant glioma.Academic Article Why?
A systematic analysis of experimental immunotherapies on tumors differing in size and duration of growth.Academic Article Why?
Diagnosis, grading and management of toxicities from immunotherapies in children, adolescents and young adults with cancer.Academic Article Why?
Low dose gemcitabine-loaded lipid nanocapsules target monocytic myeloid-derived suppressor cells and potentiate cancer immunotherapy.Academic Article Why?
CD73: an emerging checkpoint for cancer immunotherapy.Academic Article Why?
Stromal cell-based immunotherapy in transplantation.Academic Article Why?
Per Page    Page  of 42last Nextnext
Prev
Search Criteria
  • Immunotherapy
Filter by Type